Treating Venous thromboembolism with rivaroxaban

Kuritzky, Louis
March 2011
Internal Medicine Alert;2/28/2011 Supplement, p32
The article reports on a study which discovers the effectiveness of oral rivaroxaban in treating venous thromboembolism.


Related Articles

  • Newer Anticoagulants for Venous Thromboembolism.  // American Family Physician;9/15/1996, Vol. 54 Issue 4, p1361 

    Presents the results of a meta-analysis conducted to determine the efficacy and safety of low-molecular-weight heparins compared with unfractioned heparin in patients with acute venous thromboembolism. Potential advantages of low-molecular-weight heparins over unfractioned heparins; Comparison...

  • General cardiology.  // Heart;Oct2009, Vol. 95 Issue 19, p12 

    The article reports on the efficacy of rivaroxaban in preventing venous thromboembolism in patients undergoing orthopedic surgery. Results of clinical analysis show indications of the potential use of rivaroxaban in preventing venous thromboembolism. Moreover, researchers also assure that...

  • Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial. Ridker, P.M. // Vascular Medicine;1998, Vol. 3 Issue 1, p67 

    Standard therapy for patients with deep venous thrombosis and pulmonary embolism typically includes anticoagulation for a 3-6-month period with full dose warfarin. However, patients following this regimen experience high rates of recurrent thrombosis, re-hospitalization and mortality in the...

  • Unfractionated versus low-molecular-weight heparin in the treatment of venous thromboembolism. Bounameaux, H. // Vascular Medicine;1998, Vol. 3 Issue 1, p41 

    Low-molecular-weight heparin (LMWH) fractions are prepared from standard unfractionated heparin (UFH) and are thus similar to UFH in many aspects. The main advantages of this new class of antithrombotic agents as compared with UFH are: (1) an improved bioavailability and a prolonged half-life,...

  • Low-Molecular-Weight Heparin for Venous Thromboembolism. Hinchey, Kevin T. // Cortlandt Forum;Sep98, Vol. 11 Issue 9, p54 

    Analyzes the article regarding the effectiveness of low-molecular-weight heparin (LMWH) in patients with venous thromboembolism, which appeared in the 1997 issue of the `New England Journal of Medicine.' Advantages offered by LMWH; Conclusion.

  • Fixed-dose, weight-adjusted, unfractionated heparin was as effective and safe as low-molecular-weight heparin for venous thromboembolism. White, Richard H. // ACP Journal Club;Jan/Feb2007, Vol. 146 Issue 1, p1 

    The article cites a study on the treatment"of venous thromboembolism (VTE) patients, which was conducted by medical researcher C. Kearon and colleagues, and published in an issue of the "Journal of the American Medical Association." The study was concerned with the treatment of VTE patients with...

  • Longer warfarin treatment cuts risk of repeat clots. Basky, Greg // CMAJ: Canadian Medical Association Journal;6/15/99, Vol. 160 Issue 12, p1692 

    Reports the length of treatment of venous thromboembolism with warfarin, according to Canadian research as of June 15, 1999. Details of the study of Dr. Clive Kearon, associate professor of medicine at McMaster University in Hamilton, Ontario; Findings, including the benefits of extended...

  • Long-term anticoagulation means fewer recurrences of venous thromboembolism.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p12 

    Reports on a significant reduction in the incidence of recurrent venous thromboembolism when the duration of oral anticoagulant therapy was extended from 6 weeks to 6 months. Study published in the June 22, 1995, issue of `The New England Journal of Medicine'.

  • Treatment options for acute venous thromboembolism in the older patient. Rostagno, Carlo; Caciolli, Sabina; Gensini, Gian Franco // Geriatrics;Jan98, Vol. 53 Issue 1, p34 

    Suggests treatment options for patients with acute venous thromboembolism. Examination of risk factors of thromboembolism; Details on a community study conducted in Massachusetts; Discussion on findings; Suggestions made for treatment of thromboembolism.

  • Management of Venous Thromboembolism. Ginsberg, Jeffrey Stephen // New England Journal of Medicine;12/12/96, Vol. 335 Issue 24, p1816 

    Presents a review article dealing with the care of patients with venous thromboembolism, with emphasis on recent advances. Diagnosis; Thrombophilia; Treatment; Management of complications; Venous thromboembolism during pregnancy; Inferior vena caval filters and surgical thrombectomy;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics